Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma

Clinical trial NCT00556205 · WITHDRAWN

Trial details

NCT number: NCT00556205
Sponsor: Massachusetts General Hospital
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2009-09-01
Primary completion: 2009-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.